Diphenhydramine

Last updated

Diphenhydramine
Diphenhydramine 2D skeletal.svg
Diphenhydramine 3D 2aot.png
Clinical data
Pronunciation /ˌdaɪfɛnˈhaɪdrəmiːn/
Trade names Benadryl, Unisom, Nytol, others
AHFS/Drugs.com Monograph
MedlinePlus a682539
License data
Pregnancy
category
  • AU:A
Dependence
liability 		Low [1] [2]
Routes of
administration 		By mouth, intramuscular, intravenous, topical, rectal
Drug class first-generation antihistamine (ethanolamine), anticholinergic, hallucinogen (deliriant)
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability 40–60% [5]
Protein binding 98–99%
Metabolism Liver (CYP2D6, others) [6] [7]
Elimination half-life Range: 2.4–13.5  h [8] [5] [9]
Excretion Urine: 94% [10]
Feces: 6% [10]
Identifiers
  • 2-(diphenylmethoxy)-N,N-dimethylethanamine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.000.360 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C17H21NO
Molar mass 255.361 g·mol−1
3D model (JSmol)
  • O(CCN(C)C)C(c1ccccc1)c2ccccc2
  • InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 Yes check.svgY
  • Key:ZZVUWRFHKOJYTH-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold. It is also less commonly used for tremors in parkinsonism, and nausea. [11] It is taken by mouth, injected into a vein, injected into a muscle, or applied to the skin. [11] Maximal effect is typically around two hours after a dose, and effects can last for up to seven hours. [11]

Contents

Common side effects include sleepiness, poor coordination and an upset stomach. [11] Its use is not recommended in young children or the elderly. [11] [12] There is no clear risk of harm when used during pregnancy; however, use during breastfeeding is not recommended. [13] It is a first-generation H1-antihistamine and it works by blocking certain effects of histamine, which produces its antihistamine and sedative effects. [11] [2] Diphenhydramine is also a potent anticholinergic, which means it also works as a deliriant at much higher than recommended doses as a result. [14] Its sedative and deliriant effects have led to some cases of recreational use. [15] [2]

Diphenhydramine was first developed by George Rieveschl and came into commercial use in 1946. [16] [17] It is available as a generic medication. [11] It is sold under the brand name Benadryl, among others. [11] In 2021, it was the 242nd most commonly prescribed medication in the United States, with more than 1 million prescriptions. [18] [19]

Medical uses

Diphenhydramine tablets Benadryl tablets (4438315926).jpg
Diphenhydramine tablets

Diphenhydramine is a first-generation antihistamine used to treat a number of conditions including allergic symptoms and itchiness, the common cold, insomnia, motion sickness, and extrapyramidal symptoms. [20] [21] Diphenhydramine also has local anesthetic properties, and has been used as such in people allergic to common local anesthetics such as lidocaine. [22]

Allergies

Diphenhydramine is effective in treatment of allergies. [23] As of 2007, it was the most commonly used antihistamine for acute allergic reactions in the emergency department. [24]

By injection it is often used in addition to epinephrine for anaphylaxis, [25] although as of 2007 its use for this purpose had not been properly studied. [26] Its use is only recommended once acute symptoms have improved. [23]

A bottle of topical "Itch-Stopping Gel" diphenhydramine Benadryl Itch Stopping Gel (4600729217).jpg
A bottle of topical "Itch-Stopping Gel" diphenhydramine

Topical formulations of diphenhydramine are available, including creams, lotions, gels, and sprays. These are used to relieve itching and have the advantage of causing fewer systemic effects (e.g., drowsiness) than oral forms. [27]

Movement disorders

Diphenhydramine is used to treat akathisia and Parkinson's disease–like extrapyramidal symptoms caused by antipsychotics. [28] It is also used to treat acute dystonia including torticollis and oculogyric crisis caused by first generation antipsychotics.

Sleep

Because of its sedative properties, diphenhydramine is widely used in nonprescription sleep aids for insomnia. The drug is an ingredient in several products sold as sleep aids, either alone or in combination with other ingredients such as acetaminophen (paracetamol) in Tylenol PM and ibuprofen in Advil PM. Diphenhydramine can cause minor psychological dependence. [29] Diphenhydramine has also been used as an anxiolytic. [30]

Diphenhydramine has also been used off-prescription by parents in an attempt to make their children sleep and to sedate them on long-distance flights. [31] This has been met with criticism, both by doctors and by members of the airline industry, because sedating passengers may put them at risk if they cannot react efficiently to emergencies, [32] and because the drug's side effects, especially the chance of a paradoxical reaction, may make some users hyperactive. Addressing such use, the Seattle Children's hospital argued, in a 2009 article, "Using a medication for your convenience is never an indication for medication in a child." [33]

The American Academy of Sleep Medicine's 2017 clinical practice guidelines recommended against the use of diphenhydramine in the treatment of insomnia, because of poor effectiveness and low quality of evidence. [34] A major systematic review and network meta-analysis of medications for the treatment of insomnia published in 2022 found little evidence to inform the use of diphenhydramine for insomnia. [35]

Nausea

Diphenhydramine also has antiemetic properties, which make it useful in treating the nausea that occurs in vertigo and motion sickness. However, when taken above recommended doses, it can cause nausea (especially above 200 mg). [36]

Special populations

Diphenhydramine is not recommended for people older than 60 and children younger than six, unless a physician is consulted. [11] [12] [37] These people should be treated with second-generation antihistamines, such as loratadine, desloratadine, fexofenadine, cetirizine, levocetirizine, and azelastine. [38] Because of its strong anticholinergic effects, diphenhydramine is on the Beers list of drugs to avoid in the elderly. [39] [40]

Diphenhydramine is excreted in breast milk. [41] It is expected that low doses of diphenhydramine taken occasionally will cause no adverse effects in breastfed infants. Large doses and long-term use may affect the baby or reduce breast milk supply, especially when combined with sympathomimetic drugs, such as pseudoephedrine, or before the establishment of lactation. A single bedtime dose after the last feeding of the day may minimize harmful effects of the medication on the baby and on the milk supply. Still, non-sedating antihistamines are preferred. [42]

Paradoxical reactions to diphenhydramine have been documented, particularly in children, and it may cause excitation instead of sedation. [43]

Topical diphenhydramine is sometimes used especially for people in hospice. This use is without indication and topical diphenhydramine should not be used as treatment for nausea because research has not shown that this therapy is more effective than others. [44]

There were no documented cases of clinically apparent acute liver injury caused by normal doses of diphenhydramine. [45]

Adverse effects

The most prominent side effect is sedation. A typical dose creates driving impairment equivalent to a blood-alcohol level of 0.10, which is higher than the 0.08 limit of most drunk-driving laws. [24]

Diphenhydramine is a potent anticholinergic agent and potential deliriant in higher doses. This activity is responsible for the side effects of dry mouth and throat, increased heart rate, pupil dilation, urinary retention, constipation, and, at high doses, hallucinations or delirium. Other side effects include motor impairment (ataxia), flushed skin, blurred vision at nearpoint owing to lack of accommodation (cycloplegia), abnormal sensitivity to bright light (photophobia), sedation, difficulty concentrating, short-term memory loss, visual disturbances, irregular breathing, dizziness, irritability, itchy skin, confusion, increased body temperature (in general, in the hands and/or feet), temporary erectile dysfunction, and excitability, and although it can be used to treat nausea, higher doses may cause vomiting. [46] Diphenhydramine in overdose may occasionally result in QT prolongation. [47]

Some individuals experience an allergic reaction to diphenhydramine in the form of hives. [48] [49]

Conditions such as restlessness or akathisia can worsen from increased levels of diphenhydramine, especially with recreational dosages. [43] Normal doses of diphenhydramine, like other first generation antihistamines, can also make symptoms of restless legs syndrome worse. [50] As diphenhydramine is extensively metabolized by the liver, caution should be exercised when giving the drug to individuals with hepatic impairment.

Anticholinergic use later in life is associated with an increased risk for cognitive decline and dementia among older people. [51]

Contraindications

Diphenhydramine is contraindicated in premature infants and neonates, as well as people who are breastfeeding. It is a pregnancy Category B drug. Diphenhydramine has additive effects with alcohol and other CNS depressants. Monoamine oxidase inhibitors prolong and intensify the anticholinergic effect of antihistamines. [52]

Overdose

Diphenhydramine is one of the most commonly misused over-the-counter drugs in the United States. [53] In cases of extreme overdose, if not treated in time, acute diphenhydramine poisoning may have serious and potentially fatal consequences. Overdose symptoms may include: [54]

Acute poisoning can be fatal, leading to cardiovascular collapse and death in 2–18 hours, and in general is treated using a symptomatic and supportive approach. [38] Diagnosis of toxicity is based on history and clinical presentation, and in general precise plasma levels do not appear to provide useful relevant clinical information. [55] Several levels of evidence strongly indicate diphenhydramine (similar to chlorpheniramine) can block the delayed rectifier potassium channel and, as a consequence, prolong the QT interval, leading to cardiac arrhythmias such as torsades de pointes . [56] No specific antidote for diphenhydramine toxicity is known, but the anticholinergic syndrome has been treated with physostigmine for severe delirium or tachycardia. [55] Benzodiazepines may be administered to decrease the likelihood of psychosis, agitation, and seizures in people who are prone to these symptoms. [57]

Interactions

Alcohol may increase the drowsiness caused by diphenhydramine. [58] [59]

Pharmacology

Pharmacodynamics


Diphenhydramine [60]
SiteKi (nM)SpeciesRef
SERT Tooltip Serotonin transporter≥3,800Human [61] [62]
NET Tooltip Norepinephrine transporter960–2,400Human [61] [62]
DAT Tooltip Dopamine transporter1,100–2,200Human [61] [62]
5-HT2C 780Human [62]
α1B 1,300Human [62]
α2A 2,900Human [62]
α2B 1,600Human [62]
α2C 2,100Human [62]
D2 20,000Rat [63]
H1 9.6–16Human [64] [62]
H2 >100,000Canine [65]
H3 >10,000Human [62] [66] [67]
H4 >10,000Human [67]
M1 80–100Human [68] [62]
M2 120–490Human [68] [62]
M3 84–229Human [68] [62]
M4 53–112Human [68] [62]
M5 30–260Human [68] [62]
VGSC Tooltip Voltage-dependent sodium channel48,000–86,000Rat [69]
hERG Tooltip Human Ether-à-go-go-Related Gene27,100 (IC50 Tooltip Half-maximal inhibitory concentration)Human [70]
Values are Ki (nM), unless otherwise noted. The smaller the value, the more strongly the drug binds to the site.

Diphenhydramine, available in various salt forms, [71] such as citrate, [72] [73] hydrochloride, [74] and salicylate, [75] exhibits distinct molecular weights and pharmacokinetic properties. Specifically, diphenhydramine hydrochloride and diphenhydramine citrate possess molecular weights of 291.8 g/mol [76] and 447.5 g/mol, [77] respectively. These variations in molecular weight influence the dissolution rates and absorption characteristics of each salt form. Consequently, a dose of 25 mg diphenhydramine hydrochloride is therapeutically equivalent to 38 mg of diphenhydramine citrate. As such, dosage adjustments are necessary to account for these differences when switching between salt forms. [78]

Diphenhydramine, while traditionally known as an antagonist, acts primarily as an inverse agonist of the histamine H1 receptor. [79] It is a member of the ethanolamine class of antihistaminergic agents. [38] By reversing the effects of histamine on the capillaries, it can reduce the intensity of allergic symptoms. It also crosses the blood–brain barrier and inversely agonizes the H1 receptors centrally. [79] Its effects on central H1 receptors cause drowsiness.

Diphenhydramine is a potent antimuscarinic (a competitive antagonist of muscarinic acetylcholine receptors) and, as such, at high doses can cause anticholinergic syndrome. [80] The utility of diphenhydramine as an antiparkinson agent is the result of its blocking properties on the muscarinic acetylcholine receptors in the brain.

Diphenhydramine also acts as an intracellular sodium channel blocker, which is responsible for its actions as a local anesthetic. [69] Diphenhydramine has also been shown to inhibit the reuptake of serotonin. [81] It has been shown to be a potentiator of analgesia induced by morphine, but not by endogenous opioids, in rats. [82] The drug has also been found to act as an inhibitor of histamine N-methyltransferase (HNMT). [83] [84]

Overview of diphenhydramine targets and effects
Biological targetMode of actionEffect
H1 receptor Inverse agonist Allergy reduction; Sedation
mACh receptors Antagonist Anticholinergic; Antiparkinson
Sodium channels Blocker Local anesthetic

Pharmacokinetics

Oral bioavailability of diphenhydramine is in the range of 40% to 60%, and peak plasma concentration occurs about 2 to 3 hours after administration. [5]

The primary route of metabolism is two successive demethylations of the tertiary amine. The resulting primary amine is further oxidized to the carboxylic acid. [5] Diphenhydramine is metabolized by the cytochrome P450 enzymes CYP2D6, CYP1A2, CYP2C9, and CYP2C19. [6]

The elimination half-life of diphenhydramine has not been fully elucidated, but appears to range between 2.4 and 9.3 hours in healthy adults. [8] A 1985 review of antihistamine pharmacokinetics found that the elimination half-life of diphenhydramine ranged between 3.4 and 9.3 hours across five studies, with a median elimination half-life of 4.3 hours. [5] A subsequent 1990 study found that the elimination half-life of diphenhydramine was 5.4 hours in children, 9.2 hours in young adults, and 13.5 hours in the elderly. [9] A 1998 study found a half-life of 4.1 ± 0.3 hours in young men, 7.4 ± 3.0 hours in elderly men, 4.4 ± 0.3 hours in young women, and 4.9 ± 0.6 hours in elderly women. [85] In a 2018 study in children and adolescents, the half-life of diphenhydramine was 8 to 9 hours. [86]

Chemistry

Diphenhydramine is a diphenylmethane derivative. Analogues of diphenhydramine include orphenadrine, an anticholinergic, nefopam, an analgesic, and tofenacin, an antidepressant.

Detection in body fluids

Diphenhydramine can be quantified in blood, plasma, or serum. [87] Gas chromatography with mass spectrometry (GC-MS) can be used with electron ionization on full scan mode as a screening test. GC-MS or GC-NDP can be used for quantification. [87] Rapid urine drug screens using immunoassays based on the principle of competitive binding may show false-positive methadone results for people having ingested diphenhydramine. [88] Quantification can be used to monitor therapy, confirm a diagnosis of poisoning in people who are hospitalized, provide evidence in an impaired driving arrest, or assist in a death investigation. [87]

History

Diphenhydramine was discovered in 1943 by George Rieveschl, a former professor at the University of Cincinnati. [89] [90] In 1946, it became the first prescription antihistamine approved by the U.S. FDA. [91]

In the 1960s, diphenhydramine was found to weakly inhibit reuptake of the neurotransmitter serotonin. [81] This discovery led to a search for viable antidepressants with similar structures and fewer side effects, culminating in the invention of fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI). [81] [92] A similar search had previously led to the synthesis of the first SSRI, zimelidine, from brompheniramine, also an antihistamine. [93]

In 1975, diphenhydramine was still available only by prescription in the U.S. and required medical supervision. [94]

Society and culture

Diphenhydramine is deemed to have limited abuse potential in the United States owing to its potentially serious side-effect profile and limited euphoric effects, and is not a controlled substance. Since 2002, the U.S. FDA has required special labeling warning against use of multiple products that contain diphenhydramine. [95] In some jurisdictions, diphenhydramine is often present in postmortem specimens collected during investigation of sudden infant deaths; the drug may play a role in these events. [96] [97]

Diphenhydramine is among prohibited and controlled substances in the Republic of Zambia, [98] and travelers are advised not to bring the drug into the country. Several Americans have been detained by the Zambian Drug Enforcement Commission for possession of Benadryl and other over-the-counter medications containing diphenhydramine. [99]

Recreational use

Although diphenhydramine is widely used and generally considered to be safe for occasional usage, multiple cases of abuse and addiction have been documented. [15] Because the drug is cheap and sold over the counter in most countries, adolescents without access to more sought-after illicit drugs, are particularly at risk. [100] People with mental health problems—especially those with schizophrenia—are also prone to abuse the drug, which is self-administered in large doses to treat extrapyramidal symptoms caused by the use of antipsychotics. [101]

Recreational users report calming effects, mild euphoria, and hallucinations as the desired effects of the drug. [101] [102] Research has shown that antimuscarinic agents, including diphenhydramine, "may have antidepressant and mood-elevating properties". [103] A study conducted on adult males with a history of sedative abuse found that subjects who were administered a high dose (400 mg) of diphenhydramine reported a desire to take the drug again, despite also reporting negative effects, such as difficulty concentrating, confusion, tremors, and blurred vision. [104]

In 2020, an Internet challenge emerged on social media platform TikTok involving deliberately overdosing on diphenhydramine; dubbed the Benadryl challenge, the challenge encourages participants to consume dangerous amounts of Benadryl for the purpose of filming the resultant psychoactive effects, and has been implicated in several hospitalisations [105] and at least two deaths. [106] [107] [108]

Names

Diphenhydramine is sold under the brand name Benadryl by McNeil Consumer Healthcare in the U.S., Canada, and South Africa. [109] Trade names in other countries include Dimedrol, Daedalon, Nytol, and Vivinox. It is also available as a generic medication.

Procter & Gamble markets an over-the-counter formulation of diphenhydramine as a sleep aid under the brand ZzzQuil. [110]

Prestige Brands markets an over-the-counter formulation of diphenhydramine as a sleep aid in the U.S. under the name Sominex. [111]

Related Research Articles

<span class="mw-page-title-main">Hypnotic</span> Drug whose use induces sleep

Hypnotic, or soporific drugs, commonly known as sleeping pills, are a class of psychoactive drugs whose primary function is to induce sleep and to treat insomnia (sleeplessness).

H1 antagonists, also called H1 blockers, are a class of medications that block the action of histamine at the H1 receptor, helping to relieve allergic reactions. Agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines; other agents may have antihistaminergic action but are not true antihistamines.

<span class="mw-page-title-main">Benadryl</span> Brand of various antihistamine medications

Benadryl is a brand of various antihistamine medications used to stop allergies, whose content varies in different countries, but which includes some combination of diphenhydramine, acrivastine, and/or cetirizine.

<span class="mw-page-title-main">Chlorphenamine</span> Antihistamine used to treat allergies

Chlorphenamine, also known as chlorpheniramine, is an antihistamine used to treat the symptoms of allergic conditions such as allergic rhinitis. It is taken orally. The medication takes effect within two hours and lasts for about 4–6 hours. It is a first-generation antihistamine and works by blocking the H1 receptor.

<span class="mw-page-title-main">Hydroxyzine</span> Antihistamine drug

Hydroxyzine, sold under the brand names Atarax and Vistaril among others, is an antihistamine medication. It is used in the treatment of itchiness, insomnia, anxiety, and nausea, including that due to motion sickness. It is used either by mouth or injection into a muscle.

<span class="mw-page-title-main">Cetirizine</span> Antihistamine medication

Cetirizine is a second-generation antihistamine used to treat allergic rhinitis, dermatitis, and urticaria (hives). It is taken by mouth. Effects generally begin within thirty minutes and last for about a day. The degree of benefit is similar to other antihistamines such as diphenhydramine, which is a first-generation antihistamine.

<span class="mw-page-title-main">Fexofenadine</span> Antihistamine medication

Fexofenadine, sold under the brand name Allegra among others, is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever and urticaria.

<span class="mw-page-title-main">Promethazine</span> Sedating Antihistamine

Promethazine, sold under the brand name Phenergan among others, is a first-generation antihistamine, antipsychotic, sedative, and antiemetic used to treat allergies, insomnia, and nausea. It may also help with some symptoms associated with the common cold and may also be used for sedating people who are agitated or anxious, an effect that has led to some recreational use. Promethazine is taken by mouth (oral), as a rectal suppository, or by injection into a muscle (IM).

<span class="mw-page-title-main">Doxylamine</span> First-generation antihistamine used as a short-term sedative and hypnotic (sleep aid)

Doxylamine, sold under the brand name Unisom among others, is an antihistamine medication which is used in the treatment of insomnia and allergies. It is also used to treat morning sickness in pregnant women in combination with pyridoxine (vitamin B6). Doxylamine is available over-the-counter, and is used in nighttime cold medicines, such as NyQuil, as well as in pain medications containing acetaminophen and codeine, to help with sleep. The medication is taken by mouth.

<span class="mw-page-title-main">Clemastine</span> Allergy medication

Clemastine, also known as meclastin, is a first-generation H1 histamine antagonist (antihistamine) with anticholinergic properties (drying) and sedative side effects. Like all first-generation antihistamines, it is sedating.

<span class="mw-page-title-main">Doxepin</span> Medication to treat depressive disorder, anxiety disorders, chronic hives, and trouble sleeping

Doxepin is a medication belonging to the tricyclic antidepressant (TCA) class of drugs used to treat major depressive disorder, anxiety disorders, chronic hives, and insomnia. For hives it is a less preferred alternative to antihistamines. It has a mild to moderate benefit for sleeping problems. It is used as a cream for itchiness due to atopic dermatitis or lichen simplex chronicus.

<span class="mw-page-title-main">Orphenadrine</span> Muscle relaxant drug

Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class; it is closely related to diphenhydramine. It is a muscle relaxant that is used to treat muscle pain and to help with motor control in Parkinson's disease, but has largely been superseded by newer drugs. It is considered a dirty drug due to its multiple mechanisms of action in different pathways. It was discovered and developed in the 1940s.

<span class="mw-page-title-main">Trimipramine</span> Antidepressant

Trimipramine, sold under the brand name Surmontil among others, is a tricyclic antidepressant (TCA) which is used to treat depression. It has also been used for its sedative, anxiolytic, and weak antipsychotic effects in the treatment of insomnia, anxiety disorders, and psychosis, respectively. The drug is described as an atypical or "second-generation" TCA because, unlike other TCAs, it seems to be a fairly weak monoamine reuptake inhibitor. Similarly to other TCAs, however, trimipramine does have antihistamine, antiserotonergic, antiadrenergic, antidopaminergic, and anticholinergic activities.

<span class="mw-page-title-main">Dosulepin</span> Antidepressant

Dosulepin, also known as dothiepin and sold under the brand name Prothiaden among others, is a tricyclic antidepressant (TCA) which is used in the treatment of depression. Dosulepin was once the most frequently prescribed antidepressant in the United Kingdom, but it is no longer widely used due to its relatively high toxicity in overdose without therapeutic advantages over other TCAs. It acts as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also has other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects.

<span class="mw-page-title-main">Azelastine</span> Chemical compound

Azelastine, sold under the brand name Optivar among others, is a H1 receptor-blocking medication primarily used as a nasal spray to treat allergic rhinitis (hay fever) and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which it is taken by mouth. Onset of effects is within minutes when used in the eyes and within an hour when used in the nose. Effects last for up to 12 hours.

<span class="mw-page-title-main">Acrivastine</span> Chemical compound

Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine and works by blocking histamine H1 receptors.

<span class="mw-page-title-main">Tripelennamine</span> Chemical compound

Tripelennamine, sold under the brand name Pyribenzamine by Novartis, is a drug that is used as an antipruritic and first-generation antihistamine. It can be used in the treatment of asthma, hay fever, rhinitis, and urticaria, but is now less common as it has been replaced by newer antihistamines. The drug was patented at CIBA, which merged with Geigy into Ciba-Geigy, and eventually becoming Novartis.

<span class="mw-page-title-main">Mepyramine</span> First generation antihistamine

Mepyramine, also known as pyrilamine, is a first generation antihistamine, targeting the H1 receptor as an inverse agonist. Mepyramine rapidly permeates the brain, often causing drowsiness. It is often sold as a maleate salt, pyrilamine maleate.

<span class="mw-page-title-main">Antihistamine</span> Drug that blocks histamine or histamine agonists

Antihistamines are drugs which treat allergic rhinitis, common cold, influenza, and other allergies. Typically, people take antihistamines as an inexpensive, generic drug that can be bought without a prescription and provides relief from nasal congestion, sneezing, or hives caused by pollen, dust mites, or animal allergy with few side effects. Antihistamines are usually for short-term treatment. Chronic allergies increase the risk of health problems which antihistamines might not treat, including asthma, sinusitis, and lower respiratory tract infection. Consultation of a medical professional is recommended for those who intend to take antihistamines for longer-term use.

<span class="mw-page-title-main">Bilastine</span> Antihistamine medication

Bilastine is an antihistamine medication used to treat hives (urticaria), allergic rhinitis and itchy inflamed eyes (allergic conjunctivitis) caused by an allergy. It is a second-generation antihistamine and takes effect by selectively inhibiting the histamine H1 receptor, preventing these allergic reactions. Bilastine has an effectiveness similar to cetirizine, fexofenadine, and desloratadine.

References

  1. ↑ Hubbard JR, Martin PR (2001). Substance Abuse in the Mentally and Physically Disabled. CRC Press. p. 26. ISBN   978-0-8247-4497-7.
  2. 1 2 3 Saran JS, Barbano RL, Schult R, Wiegand TJ, Selioutski O (October 2017). "Chronic diphenhydramine abuse and withdrawal: A diagnostic challenge". Neurology. Clinical Practice. 7 (5): 439–441. doi:10.1212/CPJ.0000000000000304. PMC   5874453 . PMID   29620065.
  3. ↑ "Benylin Chesty Coughs (Original) - Summary of Product Characteristics (SmPC)". (emc). 24 February 2022. Archived from the original on 30 December 2022. Retrieved 29 December 2022.
  4. ↑ "Diphenhydramine- diphenhydramine hydrochloride injection, solution". DailyMed. 11 November 2019. Retrieved 18 May 2024.
  5. 1 2 3 4 5 Paton DM, Webster DR (1985). "Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)". Clinical Pharmacokinetics. 10 (6): 477–97. doi:10.2165/00003088-198510060-00002. PMID   2866055. S2CID   33541001.
  6. 1 2 Krystal AD (August 2009). "A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice". Sleep Med Rev. 13 (4): 265–74. doi:10.1016/j.smrv.2008.08.001. PMID   19153052.
  7. ↑ "Showing Diphenhydramine (DB01075)". DrugBank. Archived from the original on 31 August 2009. Retrieved 5 September 2009.
  8. 1 2 AHFS Drug Information. Published by authority of the Board of Directors of the American Society of Hospital Pharmacists. 1990. Archived from the original on 14 January 2023. Retrieved 9 October 2017.
  9. 1 2 Simons KJ, Watson WT, Martin TJ, Chen XY, Simons FE (July 1990). "Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children". Journal of Clinical Pharmacology. 30 (7): 665–71. doi:10.1002/j.1552-4604.1990.tb01871.x. PMID   2391399. S2CID   25452263.
  10. 1 2 Garnett WR (February 1986). "Diphenhydramine". American Pharmacy. NS26 (2): 35–40. doi:10.1016/s0095-9561(16)38634-0. PMID   3962845.
  11. 1 2 3 4 5 6 7 8 9 "Diphenhydramine Hydrochloride". Drugs.com. American Society of Health-System Pharmacists. 6 September 2016. Archived from the original on 15 September 2016. Retrieved 28 September 2016.
  12. 1 2 Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, et al. (November 2016). "Review of Safety and Efficacy of Sleep Medicines in Older Adults". Clinical Therapeutics. 38 (11): 2340–2372. doi: 10.1016/j.clinthera.2016.09.010 . PMID   27751669.
  13. ↑ "Diphenhydramine Pregnancy and Breastfeeding Warnings". Drugs.com. Archived from the original on 2 October 2016. Retrieved 28 September 2016.
  14. ↑ Ayd FJ (2000). Lexicon of Psychiatry, Neurology, and the Neurosciences. Lippincott Williams & Wilkins. p. 332. ISBN   978-0-7817-2468-5. Archived from the original on 8 September 2017.
  15. 1 2 Thomas A, Nallur DG, Jones N, Deslandes PN (January 2009). "Diphenhydramine abuse and detoxification: a brief review and case report". Journal of Psychopharmacology. 23 (1): 101–5. doi:10.1177/0269881107083809. PMID   18308811. S2CID   45490366.
  16. ↑ Dörwald FZ (2013). Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds. John Wiley & Sons. p. 225. ISBN   978-3-527-64565-7. Archived from the original on 2 October 2016.
  17. ↑ "Benadryl". Ohio History Central. Archived from the original on 17 October 2016. Retrieved 28 September 2016.
  18. ↑ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  19. ↑ "Diphenhydramine - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
  20. ↑ "Diphenhydramine Hydrochloride Monograph". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on 15 June 2011.
  21. ↑ Brown HE, Stoklosa J, Freudenreich O (December 2012). "How to stabilize an acutely psychotic patient" (PDF). Current Psychiatary. 11 (12): 10–16. Archived from the original (PDF) on 14 May 2013.
  22. ↑ Smith DW, Peterson MR, DeBerard SC (August 1999). "Local anesthesia. Topical application, local infiltration, and field block". Postgraduate Medicine. 106 (2): 57–60, 64–6. doi:10.3810/pgm.1999.08.650. PMID   10456039.
  23. 1 2 American Society of Health-System Pharmacists. "Diphenhydramine Hydrochloride". Drugs.com. Archived from the original on 15 September 2016. Retrieved 2 August 2016.
  24. 1 2 Banerji A, Long AA, Camargo CA (2007). "Diphenhydramine versus nonsedating antihistamines for acute allergic reactions: a literature review". Allergy and Asthma Proceedings. 28 (4): 418–26. doi:10.2500/aap.2007.28.3015. PMID   17883909. S2CID   7596980.
  25. ↑ Young WF (2011). "Chapter 11: Shock". In Humphries RL, Stone CK (eds.). CURRENT Diagnosis and Treatment Emergency Medicine. LANGE CURRENT Series (Seventh ed.). McGraw–Hill Professional. ISBN   978-0-07-170107-5.
  26. ↑ Sheikh A, ten Broek VM, Brown SG, Simons FE (January 2007). "H1-antihistamines for the treatment of anaphylaxis with and without shock". The Cochrane Database of Systematic Reviews. 2007 (1): CD006160. doi:10.1002/14651858.CD006160.pub2. PMC   6517288 . PMID   17253584.
  27. ↑ "Diphenhydramine Topical". MedlinePlus . Archived from the original on 10 October 2020. Retrieved 9 October 2020.
  28. ↑ Aminoff MJ (2012). "Chapter 28. Pharmacologic Management of Parkinsonism & Other Movement Disorders". In Katzung B, Masters S, Trevor A (eds.). Basic & Clinical Pharmacology (12th ed.). The McGraw-Hill Companies, Inc. pp. 483–500. ISBN   978-0-07-176401-8.
  29. ↑ Monson K, Schoenstadt A (8 September 2013). "Benadryl Addiction". eMedTV. Archived from the original on 4 January 2014.{{cite web}}: CS1 maint: unfit URL (link)
  30. ↑ Dinndorf PA, McCabe MA, Friedrich S (August 1998). "Risk of abuse of diphenhydramine in children and adolescents with chronic illnesses". The Journal of Pediatrics. 133 (2): 293–5. doi:10.1016/S0022-3476(98)70240-9. PMID   9709726.
  31. ↑ Crier F (2 August 2017). "Is it wrong to drug your children so they sleep on a flight?" . The Telegraph. Archived from the original on 11 January 2022. Retrieved 13 April 2020.
  32. ↑ Morris R (3 April 2013). "Should parents drug babies on long flights?". BBC News. Archived from the original on 8 March 2021. Retrieved 13 April 2020.
  33. ↑ Swanson WS (25 November 2009). "If It Were My Child: No Benadryl for the Plane". Seattle Children's. Archived from the original on 25 February 2021. Retrieved 13 April 2020.
  34. ↑ Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (February 2017). "Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline". J Clin Sleep Med. 13 (2): 307–349. doi:10.5664/jcsm.6470. PMC   5263087 . PMID   27998379.
  35. ↑ De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, et al. (July 2022). "Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis". Lancet. 400 (10347): 170–184. doi: 10.1016/S0140-6736(22)00878-9 . hdl: 11380/1288245 . PMID   35843245. S2CID   250536370.
  36. ↑ Flake ZA, Scalley RD, Bailey AG (March 2004). "Practical selection of antiemetics". American Family Physician. 69 (5): 1169–74. PMID   15023018. Archived from the original on 24 March 2016. Retrieved 10 March 2016.
  37. ↑ Medical Economics (2000). Physicians' Desk Reference for Nonprescription Drugs and Dietary Supplements, 2000 (21st ed.). Montvale, NJ: Medical Economics Company. ISBN   978-1-56363-341-6.
  38. 1 2 3 Brunton L, Chabner B, Knollmann B (2011). "Chapter 32. Histamine, Bradykinin, and Their Antagonists". In Brunton L (ed.). Goodman & Gilman's The Pharmacological Basis of Therapeutics (12e ed.). McGraw Hill. pp. 242–245. ISBN   978-0-07-162442-8.
  39. ↑ "High risk medications as specified by NCQA's HEDIS Measure: Use of High Risk Medications in the Elderly" (PDF). National Committee for Quality Assurance (NCQA). Archived from the original (PDF) on 1 February 2010.
  40. ↑ "2012 AGS Beers List" (PDF). The American Geriatrics Society. Archived from the original (PDF) on 12 August 2012. Retrieved 27 November 2015.
  41. ↑ Spencer JP, Gonzalez LS, Barnhart DJ (July 2001). "Medications in the breast-feeding mother". American Family Physician. 64 (1): 119–26. PMID   11456429.
  42. ↑ "Diphenhydramine". Drugs and Lactation Database (LactMed) Internet. Bethesda (MD): National Library of Medicine (US). October 2020. PMID   30000938.
  43. 1 2 de Leon J, Nikoloff DM (February 2008). "Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports". CNS Spectrums. 13 (2): 133–5. doi:10.1017/s109285290001628x. PMID   18227744. S2CID   10856872.
  44. ↑ American Academy of Hospice and Palliative Medicine (2013), "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation , vol. 45, no. 3, American Academy of Hospice and Palliative Medicine, pp. 595–605, doi:10.1016/j.jpainsymman.2012.12.002, PMID   23434175, archived from the original on 1 September 2013, retrieved 17 May 2024, which cites
  45. ↑ "Diphenhydramine". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. 2012. PMID   31643789. Archived from the original on 29 July 2021. Retrieved 21 June 2021.
  46. ↑ "Diphenhydramine Side Effects". Drugs.com. Archived from the original on 24 January 2009. Retrieved 6 April 2009.
  47. ↑ Aronson JK (2009). Meyler's Side Effects of Cardiovascular Drugs. Elsevier. p. 623. ISBN   978-0-08-093289-7. Archived from the original on 8 March 2021. Retrieved 4 March 2020.
  48. ↑ Heine A (November 1996). "Diphenhydramine: a forgotten allergen?". Contact Dermatitis. 35 (5): 311–312. doi:10.1111/j.1600-0536.1996.tb02402.x. PMID   9007386. S2CID   32839996.
  49. ↑ Coskey RJ (February 1983). "Contact dermatitis caused by diphenhydramine hydrochloride". Journal of the American Academy of Dermatology. 8 (2): 204–206. doi:10.1016/S0190-9622(83)70024-1. PMID   6219138.
  50. ↑ "Restless Legs Syndrome Fact Sheet". National Institute of Neurological Disorders and Stroke. Archived from the original on 28 July 2017. Retrieved 27 August 2019.
  51. ↑ Salahudeen MS, Duffull SB, Nishtala PS (March 2015). "Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review". BMC Geriatrics. 15 (31): 31. doi: 10.1186/s12877-015-0029-9 . PMC   4377853 . PMID   25879993.
  52. ↑ Sicari V, Zabbo CP (2021). "Diphenhydramine". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   30252266. Archived from the original on 28 May 2022. Retrieved 27 December 2021.
  53. ↑ Huynh DA, Abbas M, Dabaja A (2021). Diphenhydramine Toxicity. PMID   32491510.
  54. ↑ "Diphenhydramine overdose". MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine. Archived from the original on 30 May 2013.
  55. 1 2 Manning B (2012). "Chapter 18. Antihistamines". In Olson K (ed.). Poisoning & Drug Overdose (6th ed.). McGraw-Hill. ISBN   978-0-07-166833-0 . Retrieved 19 March 2013.
  56. ↑ Khalifa M, Drolet B, Daleau P, Lefez C, Gilbert M, Plante S, et al. (February 1999). "Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine". The Journal of Pharmacology and Experimental Therapeutics. 288 (2): 858–65. PMID   9918600.
  57. ↑ Cole JB, Stellpflug SJ, Gross EA, Smith SW (December 2011). "Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate". Pediatric Emergency Care. 27 (12): 1175–7. doi:10.1097/PEC.0b013e31823b0e47. PMID   22158278. S2CID   5602304.
  58. ↑ "Diphenhydramine and Alcohol / Food Interactions". Drugs.com. Archived from the original on 17 February 2013.
  59. ↑ Zimatkin SM, Anichtchik OV (1999). "Alcohol-histamine interactions". Alcohol and Alcoholism. 34 (2): 141–7. doi: 10.1093/alcalc/34.2.141 . PMID   10344773.
  60. ↑ Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Archived from the original on 20 April 2019. Retrieved 14 August 2017.
  61. 1 2 3 Tatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology. 340 (2–3): 249–58. doi:10.1016/s0014-2999(97)01393-9. PMID   9537821.
  62. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Krystal AD, Richelson E, Roth T (August 2013). "Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications". Sleep Medicine Reviews. 17 (4): 263–72. doi:10.1016/j.smrv.2012.08.001. PMID   23357028.
  63. ↑ Tsuchihashi H, Sasaki T, Kojima S, Nagatomo T (1992). "Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum". J. Pharm. Pharmacol. 44 (11): 911–4. doi:10.1111/j.2042-7158.1992.tb03235.x. PMID   1361536. S2CID   19420332.
  64. ↑ Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG (October 2006). "Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes". Bioorganic & Medicinal Chemistry. 14 (19): 6640–58. doi:10.1016/j.bmc.2006.05.077. PMID   16782354.
  65. ↑ Gantz I, Schäffer M, DelValle J, Logsdon C, Campbell V, Uhler M, et al. (1991). "Molecular cloning of a gene encoding the histamine H2 receptor". Proc. Natl. Acad. Sci. U.S.A. 88 (2): 429–33. Bibcode:1991PNAS...88..429G. doi: 10.1073/pnas.88.2.429 . PMC   50824 . PMID   1703298.
  66. ↑ Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, et al. (June 1999). "Cloning and functional expression of the human histamine H3 receptor". Molecular Pharmacology. 55 (6): 1101–7. doi:10.1124/mol.55.6.1101. PMID   10347254. S2CID   25542667.
  67. 1 2 Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, et al. (March 2001). "Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow". Molecular Pharmacology. 59 (3): 420–6. doi:10.1124/mol.59.3.420. PMID   11179434. S2CID   123619.
  68. 1 2 3 4 5 Bolden C, Cusack B, Richelson E (February 1992). "Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells". The Journal of Pharmacology and Experimental Therapeutics. 260 (2): 576–80. PMID   1346637.
  69. 1 2 Kim YS, Shin YK, Lee C, Song J (October 2000). "Block of sodium currents in rat dorsal root ganglion neurons by diphenhydramine". Brain Research. 881 (2): 190–8. doi:10.1016/S0006-8993(00)02860-2. PMID   11036158. S2CID   18560451.
  70. ↑ Suessbrich H, Waldegger S, Lang F, Busch AE (April 1996). "Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole". FEBS Letters. 385 (1–2): 77–80. Bibcode:1996FEBSL.385...77S. doi: 10.1016/0014-5793(96)00355-9 . PMID   8641472. S2CID   40355762.
  71. ↑ Wang C, Paul S, Wang K, Hu S, Sun CC (2017). "Relationships among Crystal Structures, Mechanical Properties, and Tableting Performance Probed Using Four Salts of Diphenhydramine". Crystal Growth & Design. 17 (11): 6030–6040. doi:10.1021/acs.cgd.7b01153.
  72. ↑ Rao DD, Venkat Rao P, Sait SS, Mukkanti K, Chakole D (2009). "Simultaneous Determination of Ibuprofen and Diphenhydramine Citrate in Tablets by Validated LC". Chromatographia. 69 (9–10): 1133–1136. doi:10.1365/s10337-009-0977-3. S2CID   97766056.
  73. ↑ Rao DD, Sait SS, Mukkanti K (2011). "Development and Validation of an UPLC Method for Rapid Determination of Ibuprofen and Diphenhydramine Citrate in the Presence of Impurities in Combined Dosage Form". Journal of Chromatographic Science. 49 (4): 281–286. doi:10.1093/chrsci/49.4.281. PMID   21439118.
  74. ↑ Chan CJ, Wallander KA (February 1991). "Diphenhydramine toxicity in three children with varicella-zoster infection". Dicp. 25 (2): 130–132. doi:10.1177/106002809102500204. PMID   2058184. S2CID   45456788.
  75. ↑ Kamijo Y, Soma K, Sato C, Kurihara K (November 2008). "Fatal diphenhydramine poisoning with increased vascular permeability including late pulmonary congestion refractory to percutaneous cardiovascular support". Clinical Toxicology. 46 (9): 864–868. doi:10.1080/15563650802116151. PMID   18608279. S2CID   43642257.
  76. ↑ "Diphenhydramine Hydrochloride". PubChem. U.S. National Library of Medicine.
  77. ↑ "Diphenhydramine citrate". PubChem. U.S. National Library of Medicine.
  78. ↑ Pope C (28 August 2023). "Diphenhydramine Hydrochloride vs Citrate: What's the difference?". drugs.com.
  79. 1 2 Khilnani G, Khilnani AK (September 2011). "Inverse agonism and its therapeutic significance". Indian Journal of Pharmacology. 43 (5): 492–501. doi: 10.4103/0253-7613.84947 . PMC   3195115 . PMID   22021988.
  80. ↑ Lopez AM (10 May 2010). "Antihistamine Toxicity". Medscape Reference. WebMD LLC. Archived from the original on 13 October 2010.
  81. 1 2 3 Domino EF (1999). "History of modern psychopharmacology: a personal view with an emphasis on antidepressants". Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID   10511010.
  82. ↑ Carr KD, Hiller JM, Simon EJ (February 1985). "Diphenhydramine potentiates narcotic but not endogenous opioid analgesia". Neuropeptides. 5 (4–6): 411–4. doi:10.1016/0143-4179(85)90041-1. PMID   2860599. S2CID   45054719.
  83. ↑ Horton JR, Sawada K, Nishibori M, Cheng X (October 2005). "Structural basis for inhibition of histamine N-methyltransferase by diverse drugs". Journal of Molecular Biology. 353 (2): 334–344. doi:10.1016/j.jmb.2005.08.040. PMC   4021489 . PMID   16168438.
  84. ↑ Taylor KM, Snyder SH (May 1972). "Histamine methyltransferase: inhibition and potentiation by antihistamines". Molecular Pharmacology. 8 (3): 300–10. PMID   4402747.
  85. ↑ Scavone JM, Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI (July 1998). "Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers". J Clin Pharmacol. 38 (7): 603–9. doi:10.1002/j.1552-4604.1998.tb04466.x. PMID   9702844. S2CID   24989721.
  86. ↑ Gelotte CK, Zimmerman BA, Thompson GA (May 2018). "Single-Dose Pharmacokinetic Study of Diphenhydramine HCl in Children and Adolescents". Clin Pharmacol Drug Dev. 7 (4): 400–407. doi:10.1002/cpdd.391. PMC   5947143 . PMID   28967696.
  87. 1 2 3 Pragst F (2007). "Chapter 13: High performance liquid chromatography in forensic toxicological analysis". In Smith RK, Bogusz MJ (eds.). Forensic Science (Handbook of Analytical Separations). Vol. 6 (2nd ed.). Amsterdam: Elsevier Science. p. 471. ISBN   978-0-444-52214-6.
  88. ↑ Rogers SC, Pruitt CW, Crouch DJ, Caravati EM (September 2010). "Rapid urine drug screens: diphenhydramine and methadone cross-reactivity". Pediatric Emergency Care. 26 (9): 665–6. doi:10.1097/PEC.0b013e3181f05443. PMID   20838187. S2CID   31581678.
  89. ↑ Hevesi D (29 September 2007). "George Rieveschl, 91, Allergy Reliever, Dies". The New York Times. Archived from the original on 13 December 2011. Retrieved 14 October 2008.
  90. ↑ "Benadryl". Ohio History Central. Archived from the original on 5 September 2015. Retrieved 13 August 2015.
  91. ↑ Ritchie J (24 September 2007). "UC prof, Benadryl inventor dies". Business Courier of Cincinnati. Archived from the original on 24 December 2008. Retrieved 14 October 2008.
  92. ↑ Awdishn RA, Whitmill M, Coba V, Killu K (October 2008). "Serotonin reuptake inhibition by diphenhydramine and concomitant linezolid use can result in serotonin syndrome". Chest. 134 (4 Meeting abstracts): 4C. doi:10.1378/chest.134.4_MeetingAbstracts.c4002. Archived from the original on 11 March 2016. Retrieved 19 March 2013.
  93. ↑ Barondes SH (2003). Better Than Prozac . New York: Oxford University Press. pp.  39–40. ISBN   978-0-19-515130-5.
  94. ↑ "FDA Orders Sominex 2 Withdrawn From Market". Richmond Times-Dispatch . Vol. 125, no. 336. 2 December 1975. p. 2. Retrieved 16 April 2024– via Newspapers.com.
  95. ↑ Food and Drug Administration, HHS (December 2002). "Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule". Federal Register. 67 (235): 72555–9. PMID   12474879. Archived from the original on 5 November 2008.
  96. ↑ Marinetti L, Lehman L, Casto B, Harshbarger K, Kubiczek P, Davis J (October 2005). "Over-the-counter cold medications-postmortem findings in infants and the relationship to cause of death". Journal of Analytical Toxicology. 29 (7): 738–43. doi: 10.1093/jat/29.7.738 . PMID   16419411.
  97. ↑ Baselt RC (2008). Disposition of Toxic Drugs and Chemicals in Man. Biomedical Publications. pp. 489–492. ISBN   978-0-9626523-7-0.
  98. ↑ "List of prohibited and controlled drugs according to chapter 96 of the laws of Zambia". The Drug Enforcement Commission ZAMBIA. Archived from the original (DOC) on 16 November 2013. Retrieved 20 March 2013.
  99. ↑ "Zambia". Country Information > Zambia. Bureau of Consular Affairs, U.S. Department of State. Archived from the original on 21 July 2015. Retrieved 17 July 2015.
  100. ↑ Forest E (27 July 2008). "Atypical Drugs of Abuse". Articles & Interviews. Student Doctor Network. Archived from the original on 27 May 2013.
  101. 1 2 Halpert AG, Olmstead MC, Beninger RJ (January 2002). "Mechanisms and abuse liability of the anti-histamine dimenhydrinate" (PDF). Neuroscience and Biobehavioral Reviews. 26 (1): 61–7. doi:10.1016/s0149-7634(01)00038-0. PMID   11835984. S2CID   46619422. Archived from the original (PDF) on 2 August 2020. Retrieved 23 December 2017.
  102. ↑ Gracious B, Abe N, Sundberg J (December 2010). "The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent". Journal of Child and Adolescent Psychopharmacology. 20 (6): 521–4. doi:10.1089/cap.2010.0031. PMC   3025184 . PMID   21186972.
  103. ↑ Dilsaver SC (February 1988). "Antimuscarinic agents as substances of abuse: a review". Journal of Clinical Psychopharmacology. 8 (1): 14–22. doi:10.1097/00004714-198802000-00003. PMID   3280616. S2CID   31355546.
  104. ↑ Mumford GK, Silverman K, Griffiths RR (1996). "Reinforcing, subjective, and performance effects of lorazepam and diphenhydramine in humans". Experimental and Clinical Psychopharmacology . 4 (4): 421–430. doi:10.1037/1064-1297.4.4.421.
  105. ↑ "TikTok Videos Encourage Viewers to Overdose on Benadryl". TikTok Videos Encourage Viewers to Overdose on Benadryl. Archived from the original on 8 October 2020. Retrieved 9 October 2020.
  106. ↑ "Dangerous 'Benadryl Challenge' on Tik Tok may be to blame for the death of Oklahoma teen". KFOR.com Oklahoma City. 28 August 2020. Archived from the original on 2 August 2021. Retrieved 9 October 2020.
  107. ↑ "Teen's Death Prompts Warning on 'Benadryl Challenge'". medpagetoday.com. 25 September 2020. Archived from the original on 29 September 2020. Retrieved 9 October 2020.
  108. ↑ "What is the Benadryl challenge? New TikTok challenge that's left 13-year-old dead". The Independent. 23 April 2023. Retrieved 23 April 2023.
  109. ↑ "Childrens Benadryl Allergy (solution) Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division". Drugs.com. Archived from the original on 29 July 2020. Retrieved 26 November 2019.
  110. ↑ "Is P&G Preparing to Expand ZzzQuil?". Archived from the original on 11 February 2017. Retrieved 10 February 2017.
  111. ↑ "Diphenhydramine". Mother To Baby | Fact Sheets [Internet]: Diphenhydramine. January 2023. PMID   35951938 . Retrieved 16 April 2024.{{cite book}}: |website= ignored (help)

Further reading

Commons-logo.svg Media related to Diphenhydramine at Wikimedia Commons

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.